Who is sponsoring NCT03337932?

NCT03337932 is sponsored by University Medical Centre Ljubljana.

What drugs are being tested in NCT03337932?

Interventions in NCT03337932: Doxycycline 100 milligram Oral Tablet bid, 7 days, Doxycycline 100 milligram Oral Tablet bid, 14 days, Controls without a history of lyme disease..

What condition does NCT03337932 study?

NCT03337932 studies Erythema Chronicum Migrans.

Is NCT03337932 still recruiting?

NCT03337932 is currently recruiting now. Last updated 28 March 2025.

Last reviewed 2025-03-28 · How we verify

NCT03337932

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Duration of Doxycycline Treatment in MEM Patients

Recruiting now NA Last updated 28 March 2025

What this trial tests

NA trial testing Doxycycline 100 milligram Oral Tablet bid, 7 days in Erythema Chronicum Migrans in 200 participants. Currently enrolling.

Timeline

1 May 2018

Primary endpoint
31 December 2027

31 December 2027

Quick facts

Lead sponsor	University Medical Centre Ljubljana
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	200
Start date	1 May 2018
Primary completion	31 December 2027
Estimated completion	31 December 2027
Sites	1 location across Slovenia

Drugs / interventions tested

Doxycycline 100 milligram Oral Tablet bid, 7 days — full drug profile →
Doxycycline 100 milligram Oral Tablet bid, 14 days — full drug profile →
Controls without a history of lyme disease. — full drug profile →

Conditions studied

Erythema Chronicum Migrans — all drugs for Erythema Chronicum Migrans →

Sponsor

University Medical Centre Ljubljana

Who can join

18 and older, any sex, with Erythema Chronicum Migrans. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare the efficacy of 7-day versus 14-day doxycycline treatment in patients with multiple erythema migrans.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Medical Centre Ljubljana trials

Trials by the same sponsor.

NCT07466472 — Image-Guided Central Catheter Insertion With Concurrent Assessment of Vascular Wall Integrity · not yet recruiting
NCT07446244 — Catheter Ablation of Advanced Forms of Atrial Fibrillation · NA · enrolling by invitation
NCT07109076 — Effect of Immediate Skin-to-Skin Contact on Neonatal Heart Rate Variability After Cesarean Secton · NA · recruiting
NCT07354880 — Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease · Phase 4 · not yet recruiting
NCT07496736 — Post-exposure Influenza Prophylaxis in a Hospital Setting · Phase 3 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03337932 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Medical Centre Ljubljana
Last refreshed: 28 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03337932.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing